LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · IEX Real-Time Price · USD
85.83
-0.41 (-0.48%)
Jul 26, 2024, 4:00 PM EDT - Market closed
LeMaitre Vascular Revenue
LeMaitre Vascular had revenue of $53.48M in the quarter ending March 31, 2024, with 13.60% growth. This brings the company's revenue in the last twelve months to $199.89M, up 18.16% year-over-year. In the year 2023, LeMaitre Vascular had annual revenue of $193.48M with 19.69% growth.
Revenue (ttm)
$199.89M
Revenue Growth
+18.16%
P/S Ratio
9.64
Revenue / Employee
$317,281
Employees
630
Market Cap
1.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 193.48M | 31.83M | 19.69% |
Dec 31, 2022 | 161.65M | 7.23M | 4.68% |
Dec 31, 2021 | 154.42M | 25.06M | 19.37% |
Dec 31, 2020 | 129.37M | 12.13M | 10.35% |
Dec 31, 2019 | 117.23M | 11.66M | 11.05% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Warby Parker | 697.80M |
Harmony Biosciences Holdings | 617.51M |
NeoGenomics | 610.66M |
NovoCure | 549.96M |
STAAR Surgical Company | 326.24M |
Zai Lab | 291.07M |
Mirum Pharmaceuticals | 224.00M |
Ligand Pharmaceuticals | 118.31M |
LMAT News
- 10 days ago - LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024 - GlobeNewsWire
- 2 months ago - LeMaitre to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - LeMaitre Q1 2024 Financial Results - GlobeNewsWire
- 3 months ago - LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 - GlobeNewsWire
- 4 months ago - LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 months ago - LeMaitre to Participate at Upcoming Investor Conferences in March - GlobeNewsWire
- 5 months ago - LeMaitre Q4 2023 Financial Results - GlobeNewsWire
- 5 months ago - LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024 - GlobeNewsWire